Alnylam
Alnylam Pharmaceuticals[edit | edit source]
Alnylam Pharmaceuticals is an American biopharmaceutical company recognized for its pioneering work in the domain of RNA interference (RNAi) therapeutics for the treatment of a diverse range of diseases.
History[edit | edit source]
Founded in 2002, Alnylam Pharmaceuticals derives its name from Alnilam, a star in Orion's belt. The company has dedicated nearly two decades to harnessing the power of RNAi as a new class of innovative medicines.
Core Therapeutic Areas[edit | edit source]
Alnylam focuses on a multitude of medical areas, but its standout strength is its endeavor to target genetically defined diseases using its proprietary RNAi therapeutic platform. Some key areas include:
- Cardiovascular diseases
- Hepatic infectious diseases
- Central nervous system (CNS) diseases
- Rare genetic diseases
Key Products[edit | edit source]
Alnylam has successfully introduced a series of transformative drugs into the market, such as:
- Patisiran (Onpattro) - The world's first approved RNAi therapeutic, it addresses hereditary transthyretin-mediated amyloidosis (hATTR) in adults.
- Givosiran (Givlaari) - Designed to treat acute hepatic porphyria.
- Lumasiran (Oxlumo) - A medication for primary hyperoxaluria type 1 to reduce oxalate production.
Research and Development[edit | edit source]
The company's R&D wing is driven by its commitment to innovation in RNAi therapeutics. Collaborative research programs and partnerships with leading research institutions and pharmaceutical giants are part of Alnylam's growth strategy.
Global Reach[edit | edit source]
While headquartered in Cambridge, Massachusetts, Alnylam has expanded its global operations with offices and facilities in several countries, ensuring the accessibility and availability of their groundbreaking therapies worldwide.
Corporate Initiatives[edit | edit source]
Beyond its medicinal focus, Alnylam has initiated various programs for patient support, community engagement, and sustainable business practices. The company also supports various educational initiatives aimed at enhancing knowledge about RNAi and related therapeutic avenues.
See Also[edit | edit source]
References[edit | edit source]
- [1] Alnylam Pharmaceuticals: Our Story. Accessible at: https://www.alnylam.com/about-us/our-story/
- [2] Alnylam Therapies. Retrieved from: https://www.alnylam.com/our-science/our-pipeline/
- [3] Alnylam's Global Presence. Referenced from: https://www.alnylam.com/contact-us/global-locations/
| Alnylam Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
